#htotcoron

https://rightsfreedoms.wordpress.com/20 … cinations/


57 Top Scientists and Doctors: Stop All Covid Vaccinations

9 mai 2021

Peter A. McCullough, MD, MPH
Image: Peter A. McCullough, MD, MPH is one of the experts. Press photo
A group of 57 leading scientists, doctors, and policy experts has released a report calling in to question the safety and efficacy of the current Covid-19 vaccines and are now calling for an immediate end to all vaccine programs.

This article was previously published on En-volve.com (feel free to share this report)

There are two certainties regarding the global distribution of Covid-19 vaccines. The first is that governments and the vast majority of the mainstream media are pushing with all their might to get these experimental drugs into as many people as possible. The second is that those who are willing to face the scorn that comes with asking serious questions about vaccines are critical players in our ongoing effort to spread the truth.

You can read an advanced copy of this manuscript in preprint below. It has been prepared by nearly five dozen highly respected doctors, scientists, and public policy experts from across the globe to be urgently sent to world leaders as well as all who are associated with the production and distribution of the various Covid-19 vaccines in circulation today.

There are still far too many unanswered questions regarding the Covid-19 vaccines’ safety, efficacy, and necessity. This study is a bombshell that should be heard by everyone, regardless of their views on vaccines. There aren’t nearly enough citizens who are asking questions. Most people simply follow the orders of world governments, as if they have earned our complete trust. They haven’t done so. This manuscript is a step forward in terms of accountability and the free flow of information on this crucial subject. Please take the time to read it and share it widely.

SARS-CoV-2 mass vaccination: Urgent questions on vaccine safety that demand answers from international health agencies, regulatory authorities, governments and vaccine developers

Roxana Bruno1, Peter McCullough2, Teresa Forcades i Vila3, Alexandra Henrion-Caude4, Teresa García-Gasca5, Galina P. Zaitzeva6, Sally Priester7, María J. Martínez Albarracín8, Alejandro Sousa-Escandon9, Fernando López Mirones10, Bartomeu Payeras Cifre11, Almudena Zaragoza Velilla10, Leopoldo M. Borini1, Mario Mas1, Ramiro Salazar1, Edgardo Schinder1, Eduardo A Yahbes1, Marcela Witt1, Mariana Salmeron1, Patricia Fernández1, Miriam M. Marchesini1, Alberto J. Kajihara1, Marisol V. de la Riva1, Patricia J. Chimeno1, Paola A. Grellet1, Matelda Lisdero1, Pamela Mas1, Abelardo J. Gatica Baudo12, Elisabeth Retamoza12, Oscar Botta13, Chinda C. Brandolino13, Javier Sciuto14, Mario Cabrera Avivar14, Mauricio Castillo15, Patricio Villarroel15, Emilia P. Poblete Rojas15, Bárbara Aguayo15, Dan I. Macías Flores15, Jose V. Rossell16, Julio C. Sarmiento17, Victor Andrade-Sotomayor17, Wilfredo R. Stokes Baltazar18, Virna Cedeño Escobar19, Ulises Arrúa20, Atilio Farina del Río21, Tatiana Campos Esquivel22, Patricia Callisperis23, María Eugenia Barrientos24, Karina Acevedo-Whitehouse5,*

1Epidemiólogos Argentinos Metadisciplinarios. República Argentina.
2Baylor University Medical Center. Dallas, Texas, USA.
3Monestir de Sant Benet de Montserrat, Montserrat, Spain
4INSERM U781 Hôpital Necker-Enfants Malades, Université Paris Descartes-Sorbonne Cité, Institut Imagine, Paris, France.
5School of Natural Sciences. Autonomous University of Querétaro, Querétaro, Mexico.
6Retired Professor of Medical Immunology. Universidad de Guadalajara, Jalisco, Mexico.
7Médicos por la Verdad Puerto Rico. Ashford Medical Center. San Juan, Puerto Rico.
8Retired Professor of Clinical Diagnostic Processes. University of Murcia, Murcia, Spain
9Urologist Hospital Comarcal de Monforte, University of Santiago de Compostela, Spain.
10Biólogos por la Verdad, Spain.
11Retired Biologist. University of Barcelona. Specialized in Microbiology. Barcelona, Spain.
12Center for Integrative Medicine MICAEL (Medicina Integrativa Centro Antroposófico Educando en Libertad). Mendoza, República Argentina.
13Médicos por la Verdad Argentina. República Argentina. ´
14Médicos por la Verdad Uruguay. República Oriental del Uruguay.
15Médicos por la Libertad Chile. República de Chile.
16Physician, orthopedic specialist. República de Chile.
17Médicos por la Verdad Perú. República del Perú.
18Médicos por la Verdad Guatemala. República de Guatemala.
19Concepto Azul S.A. Ecuador.
20Médicos por la Verdad Brasil. Brasil.
21Médicos por la Verdad Paraguay.
22Médicos por la Costa Rica.
23Médicos por la Verdad Bolivia.
24Médicos por la Verdad El Salvador.
* Correspondence: Karina Acevedo-Whitehouse, karina.acevedo.whitehouse@uaq.mx

Abstract

Since the start of the COVID-19 outbreak, the race for testing new platforms designed to confer immunity against SARS-CoV-2, has been rampant and unprecedented, leading to emergency authorization of various vaccines. Despite progress on early multidrug therapy for COVID-19 patients, the current mandate is to immunize the world population as quickly as possible. The lack of thorough testing in animals prior to clinical trials, and authorization based on safety data generated during trials that lasted less than 3.5 months, raise questions regarding the safety of these vaccines. The recently identified role of SARS-CoV-2 glycoprotein Spike for inducing endothelial damage characteristic of COVID-19, even in absence of infection, is extremely relevant given that most of the authorized vaccines induce the production of Spike glycoprotein in the recipients. Given the high rate of occurrence of adverse effects, and the wide range of types of adverse effects that have been reported to date, as well as the potential for vaccine-driven disease enhancement, Th2-immunopathology, autoimmunity, and immune evasion, there is a need for a better understanding of the benefits and risks of mass vaccination, particularly in the groups that were excluded in the clinical trials. Despite calls for caution, the risks of SARS-CoV-2 vaccination have been minimized or ignored by health organizations and government authorities. We appeal to the need for a pluralistic dialogue in the context of health policies, emphasizing critical questions that require urgent answers if we wish to avoid a global erosion of public confidence in science and public health.

Introduction

Since COVID-19 was declared a pandemic in March 2020, over 150 million cases and 3 million deaths have been reported worldwide. Despite progress on early ambulatory, multidrug-therapy for high-risk patients, resulting in 85% reductions in COVID-19 hospitalization and death [1], the current paradigm for control is mass-vaccination. While we recognize the effort involved in development, production and emergency authorization of SARS-CoV-2 vaccines, we are concerned that risks have been minimized or ignored by health organizations and government authorities, despite calls for caution [2-8].

Vaccines for other coronaviruses have never been approved for humans, and data generated in the development of coronavirus vaccines designed to elicit neutralizing antibodies show that they may worsen COVID-19 disease via antibody-dependent enhancement (ADE) and Th2 immunopathology, regardless of the vaccine platform and delivery method [9-11]. Vaccine-driven disease enhancement in animals vaccinated against SARS-CoV and MERS-CoV is known to occur following viral challenge, and has been attributed to immune complexes and Fc-mediated viral capture by macrophages, which augment T-cell activation and inflammation [11-13].

In March 2020, vaccine immunologists and coronavirus experts assessed SARS-CoV-2 vaccine risks based on SARS-CoV-vaccine trials in animal models. The expert group concluded that ADE and immunopathology were a real concern, but stated that their risk was insufficient to delay clinical trials, although continued monitoring would be necessary [14]. While there is no clear evidence of the occurrence of ADE and vaccine-related immunopathology in volunteers immunized with SARS-CoV-2 vaccines [15], safety trials to date have not specifically addressed these serious adverse effects (SAE). Given that the follow-up of volunteers did not exceed 2-3.5 months after the second dose [16-19], it is unlikely such SAE would have been observed. Despite92 errors in reporting, it cannot be ignored that even accounting for the number of vaccines administered, according to the US Vaccine Adverse Effect Reporting System (VAERS), the number of deaths per million vaccine doses administered has increased more than 10-fold. We believe there is an urgent need for open scientific dialogue on vaccine safety in the context of large-scale immunization. In this paper, we describe some of the risks of mass vaccination in the context of phase 3 trial exclusion criteria and discuss the SAE reported in national and regional adverse effect registration systems. We highlight unanswered questions and draw attention to the need for a more cautious approach to mass vaccination.

SARS-CoV-2 phase 3 trial exclusion criteria

With few exceptions, SARS-CoV-2 vaccine trials excluded the elderly [16-19], making it impossible to identify the occurrence of post-vaccination eosinophilia and enhanced inflammation in elderly people. Studies of SARS-CoV vaccines showed that immunized elderly mice were at particularly high risk of life-threatening Th2 immunopathology [9,20]. Despite this evidence and the extremely limited data on safety and efficacy of SARS-CoV-2 vaccines in the elderly, mass-vaccination campaigns have focused on this age group from the start. Most trials also excluded pregnant and lactating volunteers, as well as those with chronic and serious conditions such as tuberculosis, hepatitis C, autoimmunity, coagulopathies, cancer, and immune suppression [16-29], although these recipients are now being offered the vaccine under the premise of safety.

Another criterion for exclusion from nearly all trials was prior exposure to SARS-CoV-2. This is unfortunate as it denied the opportunity of obtaining extremely relevant information concerning post-vaccination ADE in people that already have anti-SARS-Cov-2 antibodies. To the best of our knowledge, ADE is not being monitored systematically for any age or medical condition group currently being administered the vaccine. Moreover, despite a substantial proportion of the population already having antibodies [21], tests to determine SARS-CoV-2-antibody status prior to administration of the vaccine are not conducted routinely.

Will serious adverse effects from the SARS-CoV-2 vaccines go unnoticed?

COVID-19 encompasses a wide clinical spectrum, ranging from very mild to severe pulmonary pathology and fatal multi-organ disease with inflammatory, cardiovascular, and blood coagulation dysregulation [22-24]. In this sense, cases of vaccine-related ADE or immunopathology would be clinically-indistinguishable from severe COVID-19 [25]. Furthermore, even in the absence of SARS-CoV-2 virus, Spike glycoprotein alone causes endothelial damage and hypertension in vitro and in vivo in Syrian hamsters by down-regulating angiotensin-converting enzyme 2 (ACE2) and impairing mitochondrial function [26]. Although these findings need to be confirmed in humans, the implications of this finding are staggering, as all vaccines authorized for emergency use are based on the delivery or induction of Spike glycoprotein synthesis. In the case of mRNA vaccines and adenovirus-vectorized vaccines, not a single study has examined the duration of Spike production in humans following vaccination. Under the cautionary principle, it is parsimonious to consider vaccine-induced Spike synthesis could cause clinical signs of severe COVID-19, and erroneously be counted as new cases of SARS-CoV-2 infections. If so, the true adverse effects of the current global vaccination strategy may never be recognized unless studies specifically examine this question. There is already non-causal evidence of temporary or sustained increases138 in COVID-19 deaths following vaccination in some countries (Fig. 1) and in light of Spike’s pathogenicity, these deaths must be studied in depth to determine whether they are related to vaccination.

Unanticipated adverse reactions to SARS-CoV-2 vaccines

Another critical issue to consider given the global scale of SARS-CoV-2 vaccination is autoimmunity. SARS-CoV-2 has numerous immunogenic proteins, and all but one of its immunogenic epitopes have similarities to human proteins [27]. These may act as a source of antigens, leading to autoimmunity [28]. While it is true that the same effects could be observed during natural infection with SARS-CoV-2, vaccination is intended for most of the world population, while it is estimated that only 10% of the world population has been infected by SARS-CoV-2, according to Dr. Michael Ryan, head of emergencies at the World Health Organization. We have been unable to find evidence that any of the currently authorized vaccines screened and excluded homologous immunogenic epitopes to avoid potential autoimmunity due to pathogenic priming.

Some adverse reactions, including blood-clotting disorders, have already been reported in healthy and young vaccinated people. These cases led to the suspension or cancellation of the use of adenoviral vectorized ChAdOx1-nCov-19 and Janssen vaccinesin some countries. It has now been proposed that vaccination with ChAdOx1-nCov-19 can result in immune thrombotic thrombocytopenia (VITT) mediated by platelet-activating antibodies against Platelet factor-4, which clinically mimics autoimmune heparin-induced thrombocytopenia [29]. Unfortunately, the risk was overlooked when authorizing these vaccines, although adenovirus-induced thrombocytopenia has been known for more than a decade, and has been a consistent event with adenoviral vectors [30]. The risk of VITT would presumably be higher in those already at risk of blood clots, including women who use oral contraceptives [31], making it imperative for clinicians to advise their patients accordingly.

At the population level, there could also be vaccine-related impacts. SARS-CoV-2 is a fast-evolving RNA virus that has so far produced more than 40,000 variants [32,33] some of which affect the antigenic domain of Spike glycoprotein [34,35]. Given the high mutation rates, vaccine-induced synthesis of high levels of anti-SARS-CoV-2-Spike antibodies could theoretically lead to suboptimal responses against subsequent infections by other variants in vaccinated individuals [36], a phenomenon known as “original antigenic sin” [37] or antigenic priming [38]. It is unknown to what extent mutations that affect SARS-CoV-2 antigenicity will become fixed during viral evolution [39], but vaccines could plausibly act as selective forces driving variants with higher infectivity or transmissibility. Considering the high similarity between known SARS-CoV-2 variants, this scenario is unlikely [32,34] but if future variants were to differ more in key epitopes, the global vaccination strategy might have helped shape an even more dangerous virus. This risk has recently been brought to the attention of the WHO as an open letter [40].

Discussion

The risks outlined here are a major obstacle to continuing global SARS-CoV-2 vaccination. Evidence on the safety of all SARS-CoV-2 vaccines is needed before exposing more people to the184 risk of these experiments, since releasing a candidate vaccine without time to fully understand the resulting impact on health could lead to an exacerbation of the current global crisis [41]. Risk-stratification of vaccine recipients is essential. According to the UK government, people below 60 years of age have an extremely low risk of dying from COVID-191 187 . However, according to Eudravigillance, most of the serious adverse effects following SARS-CoV-2 vaccination occur in people aged 18-64. Of particular concern is the planned vaccination schedule for children aged 6 years and older in the United States and the UK. Dr. Anthony Fauci recently anticipated that teenagers across the country will be vaccinated in the autumn and younger children in early 2022, and the UK is awaiting trial results to commence vaccination of 11 million children under 18. There is a lack of scientific justification for subjecting healthy children to experimental vaccines, given that the Centers for Disease Control and Prevention estimates that they have a 99.997% survival rate if infected with SARS-CoV-2. Not only is COVID-19 irrelevant as a threat to this age group, but there is no reliable evidence to support vaccine efficacy or effectiveness in this population or to rule out harmful side effects of these experimental vaccines. In this sense, when physicians advise patients on the elective administration of COVID-19 vaccination, there is a great need to better understand the benefits and risk of administration, particularly in understudied groups.

In conclusion, in the context of the rushed emergency-use-authorization of SARS-CoV-2 vaccines, and the current gaps in our understanding of their safety, the following questions must be raised:

Is it known whether cross-reactive antibodies from previous coronavirus infections or vaccine206 induced antibodies may influence the risk of unintended pathogenesis following vaccination with COVID-19?
Has the specific risk of ADE, immunopathology, autoimmunity, and serious adverse reactions been clearly disclosed to vaccine recipients to meet the medical ethics standard of patient understanding for informed consent? If not, what are the reasons, and how could it be implemented?
What is the rationale for administering the vaccine to every individual when the risk of dying from COVID-19 is not equal across age groups and clinical conditions and when the phase 3 trials excluded the elderly, children and frequent specific conditions?
What are the legal rights of patients if they are harmed by a SARS-CoV-2 vaccine? Who will cover the costs of medical treatment? If claims were to be settled with public money, has the public been made aware that the vaccine manufacturers have been granted immunity, and their responsibility to compensate those harmed by the vaccine has been transferred to the tax-payers?
In the context of these concerns, we propose halting mass-vaccination and opening an urgent pluralistic, critical, and scientifically-based dialogue on SARS-CoV-2 vaccination among scientists, medical doctors, international health agencies, regulatory authorities, governments, and vaccine developers. This is the only way to bridge the current gap between scientific evidence and public health policy regarding the SARS-CoV-2 vaccines. We are convinced that humanity deserves a deeper understanding of the risks than what is currently touted as the official position. An open scientific dialogue is urgent and indispensable to avoid erosion of public confidence in science and public health and to ensure that the WHO and national health authorities protect the interests of humanity during the current pandemic. Returning public health policy to evidence-based medicine, relying on a careful evaluation of the relevant scientific research, is urgent. It is imperative to follow the science.

1 https://www.gov.uk/government/publicati … and-report

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

Read more ….

https://newsvoice.se/2021/05/57-scienti … cinations/





.

002




#htotfauci #htotcoron


https://www.judicialwatch.org/press-rel … ss_release

JUNE 04, 2021
|
JUDICIAL WATCH
Judicial Watch Obtains Records Showing NIAID under Dr. Fauci Gave Wuhan Lab $826k for Bat Coronavirus Research From 2014 to 2019




(Washington, DC) Judicial Watch today announced that it obtained 280 pages of documents from the Department of Health and Human Services revealing that from 2014 to 2019, $826,277 was given to the Wuhan Institute of Virology for bat coronavirus research by the National Institute of Allergy and Infectious Diseases (NIAID), which is headed by Dr. Anthony Fauci.

The documents, some of which were redacted or withheld in their entirely, were obtained through a Freedom of Information Act (FOIA) lawsuit seeking records of communications, contracts and agreements with the Wuhan Institute of Virology in China (Judicial Watch, Inc. v. U.S. Department of Health and Human Services (No. 1:21-cv-00696)). The agency is only processing 300 pages records per month, which means it will take until the end of November for the records to be fully reviewed and released under FOIA.

The records include a chart of NIAID funding to the Wuhan Institute of Virology sent on April 21, 2020, by NIAID’s Chase Crawford to Principal Deputy Director Hugh Auchincloss and other NIAID officials. The agency funds directed to the Wuhan Institute of Virology between the years 2014-2019 total $826,277. All of the projects listed in the chart are titled “Understanding the Risk of Bat Coronavirus Emergence.”

In an April 15, 2020 email marked “high” importance, Principal Deputy Director of NIH Lawrence Tabak emailed Fauci, NIH Director Francis Collins, and other NIH officials with the subject line: “HEADS UP: Wuhan lab research:”

Tabak: WH has strongly embraced concerns raised by Congressman Gaetz who is publicly criticizing HHS/NIH for funding the Wuhan laboratory’s bat research. Here’s this quote from another article: “I’m disgusted to learn that for years the US government has been funding dangerous and cruel animal experiments at the Wuhan Institute, which may have contributed to the global spread of coronavirus, and research at other labs in China that have virtually no oversight from US authorities.” [Emphasis in original]

This is a large multi-country study with Wuhan being one site. The principal investigator, Peter Daszak, is based in NY at EcoHealth Alliance, Inc. [Emphasis in original]

Tabak provides details of the grant to Peter Daszak, president of EcoHealth Alliance, for a project titled “Understanding the Risk of Bat Coronavirus Emergence.” Tabak continues, saying, “The 3.7M dollar figure is over 6 years to all sites which include (several in) China, Thailand, Cambodia, Laos, Vietnam, Malaysia, Indonesia and Myanmar. We estimate that approximately $826,300 has been spent at this site since the inception of the grant. Yearly costs appear to be about 80K/year. The grant is in year 6 of a total of 10 year.”

A January 9, 2020, email exchange labeled “high” importance between NIAID Senior Scientific Advisor Dr. David Morens and Daszak details the relationship between the Fauci agency and the Wuhan Institute of Virology:

Morens: Hi guys, do any of you have any inside info on this new coronavirus that isn’t yet in the public domain? Or any thoughts?

Daszak: Yes – lots of information and I spoke with Erik Stemmy and Alan Embry yesterday before the news was released. Erik is my program officer on our coronavirus grant specifically focused on China….

Morens: Thanks, the excitement never ends, right?

Daszak: NIAID has been funding coronavirus work in China for the past 5 years … (1R01Al110964: “Understanding the Risk of Bat Coronavirus Emergence” ). That’s now been renewed … Collaborators include Wuhan Institute of Virology (currently working on the nCoV), and Ralph Baric [of University of North Carolina].

***

Also-FYI, prior to the R01, we worked under an R01 with Eun-Chung Park as program officer on viral discovery in bats, where originally identified SARS-CoV as having a likely origin in bats (published in Science)….

Morens: Great info, thanks. Tony doesn’t maintain awareness of these things and doesn’t know unless program officers tell him, which they rarely do, since they are across town and may not see him more than once a year, or less…. Interested in your feeling about where this is going. The experts are buzzing around us are all over the map, between doomsday and not that big a deal, with everything in between.

On January 23, 2020, a senior NIH official Melinda Haskins forwarded a Daily Mail article to colleagues discussing NIH/NIAID funding of the bat virus research, and noting that Fauci would be briefing senators the following morning. Haskins says, “Would you please confirm the exact nature of our support to the Wuhan Institute of Virology/Biosafety Lab.”

Another official, Barbara Mulach, responds that, “We’ve identified one grant with a sub-grant to Wuhan Institute of Virology (thanks for the lead) and one primary grant to Wuhan University. We are trying to get clarification whether or not the two organizations are related so we know if the second application is relevant to the request or not.”

She provides data showing a “Sub-award to Wuhan Institute of Virology,” with Daszak as principal investigator for a project titled, “Understanding the Risk of Bat Coronavirus Emergence,” and she provides information on another award, grant number R01AI119064-06, with principal investigator Ke Lan, going to Wuhan University and titled, “Versatile functions of LANA in KSHV pathogenesis.”

In an April 13, 2020, email from NIH official Emily Erbelding to NIH colleagues, Erbelding notes that the “entire amount of the new Daszak grant (year 6 funded in FY19) is about 3.64 M. The total amount that will go to Wuhan Institute of Virology under this grant will be about $750K ($76,301 had already been sent to Wuhan in year 1 according to the NOA).” Additionally, the email notes that bat sampling work done during years 2011-2015, in addition to receiving funding from Daszak’s grant, “could also have been supported by USAID Predict program (which was also funding the Wuhan lab).”

Auchinloss forwards Erberlding’s note to Fauci, saying, “This is higher but not extraordinarily higher than I originally indicated which was for some earlier work.” Fauci replies, “Thanks.”

In an April 15, 2020, email exchange, Tabak asks his colleagues if Daszak’s team had “published anything seminal related to the current pandemic.” Erbelding responds, “Peter’s only publication on SARS CoV2 since the epidemic began is thought piece in NEJM [New England Journal of Medicine]” to which she provides a hyperlink. She adds, “Note that all of the prior work on zoonotic reservoirs of CoV’s was also supported by USAID funding through a program called PREDICT, which has since ended.”

On October 1, 2017, after receiving Daszak’s email related to his then-unpublished paper describing detailed research into a novel bat-born virus tied to Swine Acute Diarrheal Syndrome, Fauci forwards Daszak’s email and paper on to NIH official Greg Folkers, saying, “Confidential, but fyi for you.” Daszak says, “You should know that this work was supported by a NIAID ROl that [NIH’s] Erik Stemmy is the Program Officer for, and that I’m PI [principal investigator] on, with Zhengli Shi [the director of the Center for Emerging Infectious Diseases of the Wuhan Institute of Virology] as co-PI.”

A person whose name is redacted on April 19, 2018, CCs an email to “International Cables (HHS/OS)” with the subject line “China Virus Institute Welcomes More U.S. Cooperation on Global Health Security,” includes a U.S. cable:

China’s Wuhan Institute of Virology, a global leader in virus research, is a key partner for the United States in protecting global health security. Its role as operator of the just-launched Biosafety Level 4 (or ‘P4’) lab- the first such lab in China – opens up even more opportunities for expert exchange, especially in light of the lab’s shortage of trained staff.

***

In the last year, the lab also hosted visits from the National Institutes of Health, National Science Foundation, and experts from the University of Texas Medical Branch in Galveston. The institute reports to the Chinese Academy of Sciences in Beijing.

P4 Lab is Open and Transparent, Officials Emphasize

***

Officials described the lab as a “regional node” in the global biosafety system and said it would play an emergency response role in an epidemic or pandemic. The lab’s English brochure highlighted a national security role, saying that it is “an effective measure to improve China’s availability in safeguarding national bio-safety if [a] possible biological warfare or terrorist attack happens.”

Institute officials said there would be “limited availability” for international and domestic scientists who had gone through the necessary approval process to do research at the lab. They stressed that the lab aimed to be a “worldwide, open platform” for virology. They said they welcomed U.S. Centers for Disease Control (CDC) experts, noting that the Chinese Academy of Sciences was not strong on human disease expertise, having only focused on it in the last 15 years, after the SARS outbreak. A Wuhan-based French consulate official who works on science and technology cooperation with China also emphasized that the lab, which was initiated in 2004 as a France-China joint project, was meant to be “open and transparent” to the global scientific community. “The intent was to set up a lab to international standards, and open to international research,” he said. French experts have provided guidance and biosafety training to the lab, which will continue, the French official said. Institute officials said that France provided the lab’s design and much of its technology, but that it is entirely China-funded and has been completely China-run since a “handover” ceremony in 2016.

In addition to French assistance, experts from the NIH-supported P4 lab at the University of Texas Medical Branch in Galveston have trained Wuhan lab technicians in lab management and maintenance, institute officials said.… One Wuhan Institute of Virology researcher trained for two years at the Galveston lab, and the institute also sent one scientist to U.S. CDC headquarters in Atlanta for six months’ work on influenza.

            NIH-Supported Research Revises SARS Origin Story

NIH was a major funder, along with the National Science Foundation of China (NSFC), of SARS research by the Wuhan Institute of Virology’s [redacted.]

***

Ready to Help with the Global Virome Project

Institute officials expressed strong interest in the Global Virorne Project (GVP), and said Chinese funding for the project would likely come from Chinese Academy of Sciences funding already earmarked for One Belt, One Road-related initiatives…. GVP aims to launch this year as an international collaborative effort to identify within ten years virtually all of the planet’s viruses that have pandemic or epidemic potential and the ability to jump to humans. “We hope China will be one of the leading countries to initiate the Global Virome Project,” one Wuhan Institute of Virology official said. China attended a GVP unveiling meeting in January in Thailand and is waiting for more details of the initiative. The officials said that the Chinese government funds projects similar to GVP to investigate the background of viruses and bacteria. This essentially constituted China’s own Virome Project …

***

U.S.-China Workshop Explores Research Partnerships

***

Some workshop participants also expressed skepticism about the Global Virome Project’s (GVP) approach, saying that gaining a predictive understanding of viruses with pandemic potential would require going beyond the GVPs strategy of sample collection, to take an “ecological” approach that considers the virome beyond vertebrate systems to identify mechanisms driving pathogen evolution. A follow-on workshop will be held in June at the University of Berkeley. NSF and NSFC hope to jointly announce a funding call for collaborative projects later this year.

On April 14, 2020, NIH official Marshall Bloom forwarded a Washington Post article by Josh Rogin titled “State Department Cables Warned of Safety Issues at Wuhan Lab Studying Bat Coronaviruses,” and asked a colleague to “Please send to the HCTF [High Containment Task Force]. Thanks!” 

After receiving an article via an email on November 1, 2013, from NIH official Greg Folkers with a cartoon depicting a bat depositing coronavirus particles attacking human ACE2 receptor cells, his colleague, Fauci’s Special Assistant Patricia Conrad writes, “I think we need more slides like this…its too cute!”

A January 19, 2018, State Department cable from the US Embassy in Beijing about the Wuhan Institute of Virology with the subject “China Opens First Bio Safety Level 4 Laboratory” includes a section titled “Unclear Guidelines on Virus Access and a Lack of Trained Talent Impede Research,” which notes in its introduction that “its current productivity is limited by a shortage of highly trained technicians and investigators required to safely operate a BSL-4 laboratory and a lack of clarity in related Chinese government policies and guidelines.”

The memo continues: “To date, WIV [Wuhan Institute of Virology] has obtained permission for research on three viruses: Ebola virus, Nipah virus, and Xinjiang hemorrhagic fever virus (a strain of Crimean Congo hemorrhagic fever found in China’s Xinjiang Province.)”

“These new documents show that funding for the Wuhan Institute was greater than the public has been told,” said Judicial Watch President Tom Fitton. “That it has taken a year and a federal lawsuit to get this first disclosure on COVID and Wuhan is evidence of cover-up by Fauci’s agency.”




.

Open INTRO for full Information Service
First world population death vaxxed. Cognitive thinkers, TRUMPVOTERS. Join 200 groups I found on wego !!!

Real war is to fight against the NWO UN AGENDA 2030 CRIMINALS BILDERBERGER ECOFORUM YOUNG LEADERS MACRON, TRUDEAU, ZELINSKJJ AND BIDEN MERKEL JOHNSON, MAE, SORRO, GATES THE CLINTONS OBAMA ALL FINANCED AND ORGANIZED COVID FOR STOPPING TRUMP. THIS WAR HAS TO BE FOUGHT AND NOT JUST IN UCRAINE LIKE RUSSIA DO.

#htotcoron datapool covid
#htotcoronNC Nuremberg Code

https://gab.com/SD_ECBS_newsfeed/posts/ … 3960189199

#banmrna #catchthemshreddthem #draintheswamp #hitlermakers #hightoweroftrump #globalists #nwo #fascists #nazijews #zionists #freetheusa1776 #djtthinktank4



The whole shitty James Bond NONSENSE to whitewash most evil terror org british secret service nazijew #hitlermakers #worldwarmakers RESPONSIBLE for both worldwars 1 + 2   
   
The war on jews for the creation of Israel in Immigration overrun of palestine as planned operation under the Royal House of England flag as seen in the first national flag of Israel with a fucking yellow Lion in the middle of davidstar.   
   
Holocaust on jews   
Holocaust on germans after 1945 in deathcamps like Rheinwiesen more 12 million innocent woman and children stupid war on whites makes German death 24 million more than RUSSIANS.   
   
   
Now again in 2022 same structures OPERATING in Ucraine for NEXT JEWISH worldwar for killing of the rest of white people.   
   
REFUGEES come to Germany for getting force vaxxed with jewish owned kill medical industry covid VACCINATIONS.   
   
   
http://mycoronakill.com   
http://newsagencyeurope.com
http://hitlermakers.international   
http://Hightoweroftrump.org   
http://misnicism.com   



SD_ECBS
AGENCY for NETWORKING ON THE FRONTLINES powered by the
SUPPORTERS-DESK of the EARTH COLONIES BROADCASTING SERVICE
INSTANT ENLIGHTENMENT INFORMING MACHINE (IEIM)
Guerrilla warfare INFOWARS FRONTLINE consulting
THE SOCIAL NETWORKS MAXIMUM EFFECT
#earthoptimization #enlightenment2012 #misnicism #SD_ECBS_newsfeed
#SD_ECBS_disclosurelobby #hitlertriangle #hightoweroftrump #DJTthinktank4


   
   
.

Vaxx danger SECTION 2 related grapheneoxide
conterminated medical products for decades even Nurofen
IN GENERAL GRAPHENEOXIDE IN GENERAL ARE USED IN NANOPARTICLES SPREAD IN CHEMTRAILS SINCE DECADES:

IN THE HUMAN BODY IT CREATES TROMBOSIS MEANS HEARTATTACKS BRAINDAMAGES WHATEVER. AS FACT THAT THESE NANOPARTICLES ARE EXPRENSIVE TO PRODUCE AND GRAPHITE A SATANIC ELEMENT IS PROOF OD NWO UN AGENDA 2030 CRIME PAID BY ZIONISTS MONEY PLANNED BY ZIONISTS INVOLVED


GATES
KISSINGER
SORRO




THE WIFE OF GERMAN RESEARCHER DR. NOACK
KILLED  GERMAN POLICE GESTAPO STYLE INVOLVED RECORDED DURING A LIVE INTERNET SESSION EUROPEAN WIDE WITH 4 OTHER EXPERTS.

ANDREAS NOACK WAS ABOUT
A INTERNET DISCUSSION OF THE DANGER OF GRAPHITEOXIDE
FOUND BY SPANISH SCIENTIST IN SEVERAL SO CALLED COVID VACCINES
AS PROOF OF PLANNED KILL JUICE



THE WIFE AFTER THE KILL OF HIS HUSBAND

https://www.brighteon.com/801be0e1-1e9e … 0a018d6403



SECTION 4 COVID 19 VACCINATION
GRAPHITEOXIDE KILL OUT OF 40 OTHER KILL PARTS OF THE VACCINATIONS IN GENERAL

http://supporters-desk.com/ Board link: Topic




CLIMAX OVERVIEW

http://supporters-desk.com/ Board link: Topic



BEST OF DISCLOSE OF THE WORLDWIDE PLANDEMIC GENOCIDE

https://www.bitchute.com/video/K1ZErvirC5w4




http://mycoronakill.com


NUROFEN WITH HIDDEN GRAPHINEOXIDE IN PAINTABLETTS

https://gab.com/SD_ECBS_newsfeed/posts/ … 7160717154



“How do you tell someone who took the Covid 19 Vaccine that tiny razor blades were injected into their bodies?” - Victor-Hugo Vaca II

https://www.bitchute.com/video/aaD0Yj5AUZko





.

#closeCNN #fakeNEWS WRONG INFORMATION OR BLOCKING INFORMATION IN A MASS KILLING PLANDEMIC IS A CRIMINAL ACT UNDER MILITARY LAW MEANS DEATH PENALTY YOU ASSHOLES!!!

https://www.bitchute.com/video/PFQxiDUq40sh

UCRAINE FAKE WAR FOR SAVING THEIR #CORONASPRAYERS ASSES

https://www.bitchute.com/video/YB9eTKvvU7df/

#htotfia #freeinformationact #aaronswartz #newsongab #myspace #facebook #fuckblock #freespeech #nwo_OPS #earthoptimization #enlightenment2012 #misnicism
#draintheswamp #EVILPHARAOEMPIRE #hitlermakers #hightoweroftrump #htotfn

FUCK THE NEW WORLD ORDER
NWO UN AGENDA 2030 CRIME OF THE
MASON BILDERBERGER TALMUDORDER ILLUMINATI NAZIJEW FUCKERS OWNED #nwomediabot
ALL WESTERN CHRISTIAN NATIONS NEWS TV AND NEWSPAPERS ARE NAZIJEW ILLUMINATI OWNED

https://gab.com/groups/58545

enjoy the #SD_ECBS_newsfeed

https://www.bitchute.com/channel/ziJRmzzdvEEN/



#htotfia datapool #FREEINFORMATIONACT is a human right against the NWO UN AGENDA 2030 CRIME #coronasprayers http://newsagencyeurope.com
http://copyandpastewillhealtheworld.com
http://my5Gkill.com
http://mycoronakill.com
http://hightoweroftrump.org
http://supporters-desk.com

Presented by the
http://EARTH-COLONIES-BROADCASTING-SERVICE.NET


: